Infinity Pharmaceuticals

Filed a patent for "combination therapies" on Thu, January 23, 2025

Filed a patent for "combination therapies" on Thu, March 9, 2023

Filed a patent for "combination therapies" on Thu, October 3, 2024

Filed a patent for "combination therapies" on Thu, September 5, 2024

Filed a patent for "heterocyclic compounds and uses thereof" on Thu, February 15, 2024

Filed a patent for "treatment of cancers using pi3 kinase isoform modulators" on Thu, November 16, 2023

Filed a patent for "formulations of (s)-3-(1-(9h-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2h)-one" on Thu, April 6, 2023